Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Men with HPV are 20 times more likely to be reinfected after one year

An analysis of HPV in men shows that infection with one type strongly increased the risk of reinfection of the same type. The study highlights the importance of vaccination for preventing the spread of HPV in young men before they become sexually active and in older men who have already contracted the virus.

Published
06 December 2017
From
Eurekalert Inf Dis
HIV-positive transgender men in US have significant unmet medical and social needs

HIV-positive transgender men in the United States have significant unmet social and healthcare needs, according to a study published in Research and Practice. Approximately half were living in

Published
06 December 2017
By
Michael Carter
What Do Transgender Women Want? Lessons Learned by Listening

When taken correctly, PrEP nearly eliminates the risk of HIV. Yet, for transgender women, seeking protection against HIV may come second to safety, mental health, and employment opportunities.

Published
05 December 2017
From
The Body Pro
Older antiretroviral regimens raise diabetes risk in HIV-positive adults

HIV-positive adults who initiated older formulations of antiretroviral therapy are more likely to develop type 2 diabetes than patients who initiated therapy between 2010 and 2015, according to study findings reported in BMJ Open Diabetes Research.

Published
05 December 2017
From
Healio
Analysis: Trump PEPFAR strategy, budget proposals add up to surrender in HIV battle

White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of countries represents an unprecedented retreat from American leadership of the global fight against the disease and would reverse gains that were achieved, at a cost of more than $80 billion, over the last 15 years, according to a ONE analysis released on World AIDS Day.

Published
05 December 2017
From
Science Speaks
Opinion: The UK needs stronger political leadership — and investment — to fight AIDS

"The U.K. must increase its contributions to multilateral organizations working on the HIV response, including the Global Fund, UNAIDS, and UNITAID, if we are to meet the [Sustainable Development Goal (SDG)] target on AIDS. Beyond the financing, the U.K. also has a critical role to play in using its political leadership and global influence to promote and protect the rights of the groups at the greatest risk of being left behind."

Published
05 December 2017
From
Devex
Portugal’s radical drugs policy is working. Why hasn’t the world copied it?

The Long Read: Since it decriminalised all drugs in 2001, Portugal has seen dramatic drops in overdoses, HIV infection and drug-related crime.

Published
05 December 2017
From
The Guardian
Statement on behalf of the Council of Chief Medical Officers of Health

"Across studies to date, there have been no confirmed cases of sexually transmitted HIV to an HIV-negative partner when the HIV-positive partner was continuously on antiretroviral therapy (ART) with sustained viral suppression. We have known for some time that ART is critical for maintaining and improving the health of a person living with HIV. It has also become evident that when a person living with HIV is on ART, takes their medications consistently as prescribed and maintains a confirmed suppressed viral load, there is effectively no risk of their passing the infection on to their sex partners."

Published
05 December 2017
From
Public Health Agency of Canada
Harm reduction on a knife edge

Disinvestment in harm reduction is hurting services and failing clients, say those struggling to maintain life-saving provision.

Published
04 December 2017
From
Drink & Drug News
HIV drug resistance now high enough to trigger a change in first-line treatment in eastern and southern Africa

HIV drug resistance is increasing rapidly in southern and eastern Africa and Latin America and, as a result, it may soon be necessary to change the

Published
04 December 2017
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.